Trending

Sosei

Pfizer selects first GPCR candidate from Sosei Heptares tie-up

Pfizer selects first GPCR candidate from Sosei Heptares tie-up

Pfizer has selected the first drug candidate from a collaboration with Sosei Group to develop drugs for major

X

Pfizer selects first GPCR candidate from Sosei Heptares tie-up

https://pharmaphorum.com/news/pfizer-selects-first-gpcr-candidate-from-sosei-heptares-tie-up/

Shinichi Tamura re-takes CEO role at Sosei

Shinichi Tamura re-takes CEO role at Sosei

Sosei has announced that its founder and former CEO Shinichi Tamura will be re-taking the position of CEO

X

Shinichi Tamura re-takes CEO role at Sosei

https://pharmaphorum.com/news/shinichi-tamura-re-takes-ceo-role-sosei/

Sosei shares tank after safety issue with Alzheimer’s drug

Sosei shares tank after safety issue with Alzheimer’s drug

Allergan and Sosei’s experimental Alzheimer’s medicine has run into trouble – the companies have called a halt to

X

Sosei shares tank after safety issue with Alzheimer’s drug

https://pharmaphorum.com/news/sosei-shares-tank-after-safety-issue-with-alzheimers-drug/

Sosei see Teva pipeline cull as an opportunity

Sosei see Teva pipeline cull as an opportunity

Troubled generics giant Teva is continuing the heavy pruning of its business and has cut a novel migraine drug from its pipeline.

X

Sosei see Teva pipeline cull as an opportunity

https://pharmaphorum.com/news/sosei-loses-teva-culls-migraine-pipeline/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com